Brad H Rovin Selected Research

Cyclophosphamide (Cytoxan)

5/2024	Impact of glucocorticoid dose on complete response, serious infections, and mortality during the initial therapy of lupus nephritis: A systematic review and meta-analysis of the control arms of randomized controlled trials.
1/2022	A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis.
1/2021	The STARMEN trial: rethinking calcineurin inhibitor therapy in membranous nephropathy.
11/2020	Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
1/2020	Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
1/2018	Induction Therapy for Lupus Nephritis: the Highlights.
1/2017	The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
10/2016	Current and Emerging Therapies for Lupus Nephritis.
1/2013	Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
2/2012	Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brad H Rovin Research Topics

Disease

57	Lupus Nephritis 05/2024 - 10/2006
33	Proteinuria 05/2024 - 03/2004
27	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 07/2002
19	Inflammation (Inflammations) 12/2023 - 08/2001
14	Nephritis 09/2023 - 07/2002
13	IGA Glomerulonephritis (IGA Nephropathy) 12/2023 - 05/2016
10	Infections 05/2024 - 10/2002
9	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2022 - 12/2004
9	Glomerulonephritis 08/2021 - 07/2002
8	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2010
8	Chronic Renal Insufficiency 01/2019 - 11/2009
7	Kidney Diseases (Kidney Disease) 02/2021 - 10/2009
7	Diabetic Nephropathies (Diabetic Nephropathy) 11/2018 - 03/2004
6	Hematuria 01/2023 - 10/2011
5	Chronic Kidney Failure (Chronic Renal Failure) 06/2022 - 12/2008
5	Autoimmune Diseases (Autoimmune Disease) 02/2021 - 06/2007
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2018 - 03/2004
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 03/2024 - 01/2010
4	Fibrosis (Cirrhosis) 12/2023 - 08/2012
4	Hypertension (High Blood Pressure) 12/2023 - 01/2012
3	COVID-19 09/2022 - 01/2020
3	Vasculitis (Vasculitides) 10/2021 - 01/2017
3	Anemia 11/2020 - 02/2013
3	Diabetes Mellitus 09/2017 - 07/2006
2	Neoplasms (Cancer) 01/2024 - 09/2009
2	Atrophy 12/2023 - 08/2012
2	Disease Progression 05/2023 - 09/2014
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2021 - 08/2020
2	Hemorrhage 11/2020 - 06/2013
2	Necrosis 10/2020 - 08/2012
2	Body Weight (Weight, Body) 01/2020 - 01/2019
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017 - 09/2008
2	Atherosclerosis 04/2012 - 05/2006
2	Obesity 04/2012 - 07/2006
2	Lipoprotein Glomerulopathy 10/2010 - 12/2007
1	Renal Insufficiency (Renal Failure) 12/2023

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2005
26	CreatinineIBA 12/2023 - 10/2005
20	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2004
16	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 04/2005
10	Rituximab (Mabthera)FDA Link 01/2022 - 12/2008
9	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2010
8	GlucocorticoidsIBA 05/2024 - 08/2005
8	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2024 - 12/2004
8	Complement System Proteins (Complement)IBA 12/2023 - 01/2004
8	Antigen-Antibody Complex (Immune Complex)IBA 07/2023 - 07/2002
6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2024 - 05/2016
6	belimumabIBA 11/2023 - 01/2020
6	AutoantibodiesIBA 02/2021 - 09/2014
5	Calcineurin InhibitorsIBA 01/2021 - 05/2013
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 12/2008
5	ChemokinesIBA 01/2008 - 08/2001
4	Immunosuppressive Agents (Immunosuppressants)IBA 05/2024 - 12/2004
4	Immunoglobulin A (IgA)IBA 12/2023 - 05/2007
4	CytokinesIBA 12/2023 - 08/2001
4	AntibodiesIBA 01/2022 - 01/2009
4	Antinuclear AntibodiesIBA 01/2019 - 01/2017
4	HepcidinsIBA 04/2015 - 12/2010
3	Prednisone (Sone)FDA LinkGeneric 05/2024 - 08/2005
3	Budesonide (Pulmicort)FDA LinkGeneric 07/2023 - 01/2023
3	Immunoglobulins (Immunoglobulin)IBA 08/2021 - 12/2008
3	Immunoglobulin G (IgG)IBA 02/2021 - 01/2016
3	Cytotoxins (Cytolysins)IBA 10/2016 - 12/2008
3	Monoclonal AntibodiesIBA 01/2016 - 12/2008
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2015 - 10/2002
3	ProteomeIBA 05/2012 - 03/2004
3	AdiponectinIBA 07/2009 - 10/2005
3	Complement C4 (Complement Component 4)IBA 06/2007 - 01/2004
2	avacopanIBA 03/2024 - 11/2020
2	Angiotensin Receptor AntagonistsIBA 12/2023 - 04/2017
2	EnzymesIBA 12/2023 - 01/2017
2	obinutuzumabIBA 11/2023 - 01/2022
2	Azathioprine (Imuran)FDA LinkGeneric 01/2022 - 01/2020
2	Bortezomib (Velcade)FDA Link 08/2021 - 06/2020
2	Pancreatic Elastase (Elastase)IBA 08/2021 - 03/2004
2	voclosporinIBA 01/2021 - 01/2019
2	Dabigatran FDA Link 01/2021 - 02/2015
2	AnticoagulantsIBA 01/2021 - 02/2015
2	IronIBA 01/2021 - 03/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 01/2015
2	inositol pentaphosphate (inositol pentakisphosphate)IBA 11/2018 - 09/2009
2	SteroidsIBA 01/2018 - 08/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2009
2	Peptides (Polypeptides)IBA 01/2017 - 09/2009
2	bromfenacoum (Ratak)IBA 01/2015 - 10/2011
2	AutoantigensIBA 12/2014 - 09/2014
2	apolipoprotein E2 (Kyoto)IBA 10/2010 - 12/2007
2	ProstaglandinsIBA 09/2005 - 08/2001
1	TeratogensIBA 01/2024
1	Irbesartan FDA LinkGeneric 12/2023
1	Endothelins (Endothelin)IBA 12/2023
1	sparsentanIBA 12/2023
1	Syk KinaseIBA 12/2023
1	chemotactic factor inactivatorIBA 12/2023

Therapy/Procedure

40	Therapeutics 05/2024 - 12/2004
4	Nephrectomy 01/2021 - 05/2007
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 01/2019
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 12/2008
2	Lasers (Laser) 05/2012 - 09/2009
1	Holistic Health (Holistic Medicine) 12/2023